Financial Data and Key Metrics Changes - Revenue increased by 36.7% year-over-year to $49.3 million in Q3 2025, with a 29% increase excluding Keystone [11][12] - Medical segment-adjusted EBITDA margin rose to 15.1% in Q3 2025 from 12.5% in the first half of the year [12][13] - Free cash flow from continuing operations was approximately $2 million for the quarter [13] Business Line Data and Key Metrics Changes - Organ placement services revenue more than doubled year-over-year, indicating strong growth in this area [11] - Air logistics contributed significantly to organic revenue growth, with new and existing customers driving strong results [11][12] - Keystone's revenue increased over 40% year-over-year for the full month of September, despite only contributing $2.8 million for half of Q3 [12] Market Data and Key Metrics Changes - Industry-wide NRP adoption rates continued to increase, with transplants of organs undergoing NRP approximately doubling compared to the prior year [9][10] - Despite a seasonal decline in industry transplant volumes of approximately 6%, the company achieved a 3% sequential revenue increase [11] Company Strategy and Development Direction - The company has rebranded as Strata Critical Medical and shifted focus to healthcare, aiming for long-term growth and value creation [5] - The integration of Keystone Perfusion is expected to enhance operational efficiencies and cost savings for the transplant community [8][9] - The company plans to leverage local resources to reduce transportation costs and improve service delivery [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong demand seen in Q3, leading to an increase in 2025 revenue guidance to a range of $185 million-$195 million [16] - The company anticipates continued growth driven by new customer acquisitions and market share consolidation in a fragmented marketplace [22] - Management acknowledged the impact of seasonal factors on transplant volumes but emphasized the company's ability to grow through these challenges [39] Other Important Information - The company ended the quarter with no debt and approximately $76 million in cash and short-term investments [15] - The Joby transaction closed during the quarter, with cash proceeds of approximately $70 million from monetizing shares [15] Q&A Session Summary Question: Can you provide a disaggregation of where the growth came from in terms of revenue during Q3? - Management indicated that growth was driven by a mix of new customer acquisition and strength within existing customers, with new services contributing to the results [20][21] Question: Do you see the growth coming from similar directions in the future? - Management expects continued customer additions and market share consolidation, supported by favorable industry growth dynamics [22] Question: What should we expect in terms of fleet margin and maintenance impact for the remainder of the year? - Management noted that scheduled maintenance events have decreased and margins are expected to improve sequentially [23] Question: How many individual customers are being served now with the Keystone acquisition? - The company serves almost 250 different customers across cardiac care and transplant businesses, providing geographic diversity [29] Question: Is there any customer that constitutes 5% or more of revenues? - Management stated that the business is diversified, and they do not break out customer contributions by business line [30] Question: Are you evening out the revenue sides between air and ground logistics? - Air remains the larger part of the business, but the Keystone acquisition provides opportunities for ground logistics growth [32] Question: Will you break out logistics versus perfusionist side in the future? - Management indicated that a pro forma business mix will be provided in the investor deck, reflecting the expected future mix [33]

Financial Data and Key Metrics Changes - The third quarter of 2025 saw production rates sustained at 90% capacity, with a new record monthly production volume achieved in October [5][6] - The company announced a new $130 million six-year debt facility from Ganfeng, enhancing its debt profile while preserving shareholder value [5][6] - Cash costs increased by approximately 3% to $6,300 per ton due to a slight decrease in production [66][67] Business Line Data and Key Metrics Changes - The PPG project is expected to have a Stage one LCE capacity of 50,000 tons per year, expanding to 150,000 tons per year in three phases, with an initial capital investment estimated at $1.1 billion [12][13] - The total life of mine capital for the PPG project is estimated at $3.3 billion, with a strong after-tax NPV of $8.2 billion at an 8% discount rate [13][12] Market Data and Key Metrics Changes - The lithium market is projected to require approximately 1 million tons of new LCE capacity over the next decade to meet global demand, supporting long-term pricing levels [13][14] - The long-term price of lithium carbonate is projected at $18,000 per ton, with an IRR of over 20% even at a conservative price estimate of $12,000 per ton [13][74] Company Strategy and Development Direction - The company aims to sustain higher production levels while positioning itself for long-term growth, focusing on the PPG project as a key growth driver [5][34] - The partnership with Ganfeng is highlighted as a significant factor in achieving low-cost growth and technological innovation in Argentina [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting production targets for 2025 and emphasized the importance of the collaborative partnership with Ganfeng [4][6] - The company is optimistic about the lithium market's evolution, particularly the demand for energy storage systems (ESS), which may surpass the electric vehicle (EV) market [15][92] Other Important Information - The Argentine government’s RIGI program is expected to provide competitive incentives and clarity on foreign exchange regulations, enhancing the project's value [17][18] - The PPG project has received environmental permits, allowing for the submission of the RIGI application in 2026 [18][34] Q&A Session Summary Question: What is the reason for the low capital intensity of the PPG project compared to other projects? - The lower capital intensity is attributed to the high quality of the resource and the use of new processing technologies designed to reduce the capital footprint [37][38] Question: What additional permits are required for the PPG project? - The company needs to apply for regional and water permits, which are expected to be approved in a few months [56][58] Question: How does the company plan to minimize equity dilution risk for shareholders? - The company has a strong track record of executing strategic financings and plans to leverage partnerships and project-level debt to minimize shareholder dilution [70][69] Question: What is the rationale for using $18,000 per ton as a long-term price for lithium? - The $18,000 price is aligned with third-party forecasts and is deemed necessary to incentivize new project developments over the next decade [74][73] Question: What is the current status of material quality and the timeline for achieving battery-grade product? - The company is making gradual improvements in product quality and aims to supply battery-grade product by 2026-2027 [81][82]

Financial Data and Key Metrics Changes - Total Payment Volume (TPV) grew by 18%, revenue increased by 10%, and net income rose by 12% year-over-year [3] - Excluding the impact of smartphone supply issues, revenue would have increased by 32% and net income by 16% [3][5] - The fintech segment reported a 16% growth in Total Financial Volume (TFV) and a 24% increase in revenue [4][39] Business Line Data and Key Metrics Changes - The marketplace experienced a 12% growth year-over-year, with a 20% GMV growth when excluding smartphone impacts [3][33] - E-grocery GMV grew by 53%, with transaction growth at 55%, reaching 1.3 million customers [7] - Advertising revenue surged by 56% year-over-year, indicating strong growth in this segment [13][36] Market Data and Key Metrics Changes - The smartphone supply disruption had an 8% impact on GMV and a 3% impact on consolidated income [5][33] - The overall e-commerce market remains strong, with GMV growth of 12% in the third quarter, and 19% for the nine-month period, excluding smartphones [33][34] Company Strategy and Development Direction - The company is focusing on enhancing its payment options, marketing, delivery, and user experience to drive growth [25][42] - Plans to expand into new cities and increase the number of dark stores for e-grocery services are underway [7][8] - The introduction of innovative payment methods, such as Pay by Palm, aims to enhance consumer flexibility [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about recovering demand in the next year despite current supply chain challenges [5][62] - The competitive position in e-commerce remains strong, with expectations for normalization of growth as supply issues resolve [34][62] - The company anticipates a favorable base effect starting in March 2026, which should support growth [46][62] Other Important Information - A $400 million ADS buyback program is set to commence, reflecting strong cash generation and performance [4][47] - The company is also exploring the introduction of dividend payments in the future [47] Q&A Session Summary Question: Updates on Hepsiburada and investment levels - Management emphasized the focus on quality services and consumer engagement as key priorities for growth, with no significant need for capital investments unless justified [51][52] Question: Insights on advertising product growth - Management highlighted the development of a full range of advertising services, with expectations for faster growth than overall revenue [54] Question: Marketplace take rate increase - The increase in take rate is driven by additional services, particularly advertising and delivery, rather than higher seller fees [56] Question: Smartphone supply impact - Management confirmed ongoing supply constraints for new smartphone models but expects normalization in the coming months, with strong growth in non-smartphone categories [60][62]

Financial Data and Key Metrics Changes - In Q3 2025, the company reported 83.4 million orders, a 14% increase year over year, leading to a Gross Transaction Value (GTV) of $9.17 billion, up 10% year over year [20] - Average order value decreased by 4% year over year, primarily due to growth in restaurant orders and the introduction of a $10 basket minimum for Instacart+ members [21] - GAAP net income was $144 million, up 22% year over year, and adjusted EBITDA also grew 22% year over year to $278 million [22] - Operating cash flow increased by $102 million year over year to $287 million [22] - The company repurchased $67 million worth of shares in Q3 and ended the quarter with approximately $1.9 billion in cash and similar assets [22] Business Line Data and Key Metrics Changes - The marketplace remains the backbone of the business, with a growing and loyal customer base, leading to increased order frequency and spending [5][6] - Advertising and other revenue grew 10% year over year, representing 2.9% of GTV, which was flat year over year [21] - The enterprise platform is a key growth driver, with over 350 retailer e-commerce storefronts powered by the company's technology [8][12] Market Data and Key Metrics Changes - The company is expanding its international presence, focusing on Europe and Australia, leveraging existing products like Storefront, Caper, and FoodStorm [18][39] - The advertising ecosystem has diversified, with partnerships established with platforms like TikTok and Pinterest, enhancing the company's reach [15][16] Company Strategy and Development Direction - The company aims to enhance affordability, accelerate enterprise growth, and innovate its advertising ecosystem [27][28][30] - The launch of AI solutions is expected to provide a competitive advantage and enhance the shopping experience for consumers [10][32] - The company emphasizes its role as a technology and enablement partner for the grocery industry, not just a marketplace [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive sustainable growth, citing strong fundamentals and multiple growth engines [18][24] - The company anticipates GTV for Q4 to range between $9.45 billion and $9.6 billion, reflecting year-over-year growth of 9%-11% [23] - Management acknowledged potential near-term pressures from large brand partners adjusting their spending due to macroeconomic uncertainties [24] Other Important Information - The company increased its share repurchase program by $1.5 billion, underscoring confidence in its future [19] - The enterprise platform is seen as a strategic growth lever, with opportunities to deepen relationships with retailers [12] Q&A Session Summary Question: What are the biggest strategic investments for growth? - Management highlighted three focus areas: affordability, accelerating enterprise growth, and enhancing the advertising ecosystem [26][27][30] Question: How will AI solutions be monetized? - AI solutions will provide smarter operations and personalized shopping experiences, creating monetization opportunities for the company [31][32] Question: What is the impact of new partnerships and international growth plans? - New partnerships are expected to drive significant growth, with a disciplined approach to international expansion [38][39] Question: How does the competitive environment affect pricing strategies? - The company is actively engaging with retailers on pricing strategies to remain competitive against players like Amazon [51] Question: What is the contribution of enterprise solutions to overall business? - Enterprise solutions enhance order density and provide cost-to-serve advantages, contributing positively to the bottom line [55][56]

Financial Data and Key Metrics Changes - The company reported a loss from continuing operations, net of tax, of $166 million for the quarter [26] - Cash and cash equivalents stood at $4.4 billion, with no debt on the balance sheet, indicating a strong capital position [26][27] Business Line Data and Key Metrics Changes - The company has initiated potentially registrational trials in multiple areas including Graves' disease, myasthenia gravis, CIDP, and others, indicating a robust pipeline [6][8] - The NDA filing for BREPO is on track for the first half of next year, which could be the first novel oral therapeutic in dermatomyositis if approved [5][7] Market Data and Key Metrics Changes - The company highlighted a significant unmet need in the dermatomyositis patient population, with 75% of patients currently on either steroids or immunosuppressive therapies [11][12] - In Graves' disease, there are approximately 880,000 diagnosed patients in the U.S., with a significant portion unable to achieve well-controlled status [20][21] Company Strategy and Development Direction - The company is focused on expanding its late-stage pipeline, with 11 potentially registrational trials and indications with blockbuster potential [7][8] - The management emphasized the importance of addressing the unmet medical needs in various diseases, particularly in Graves' disease and dermatomyositis [18][19] Management Comments on Operating Environment and Future Outlook - Management expressed excitement about the transformative data from recent trials and the potential for future growth [4][9] - The company plans to provide more detailed insights into its future strategy during the upcoming investor day on December 11, 2025 [27][28] Other Important Information - The company has a favorable marketing ruling in the Pfizer case and is making progress in ongoing litigation related to LNP [6][25] - The TED study is on track to conclude this year, with top-line data expected to be reported in conjunction with data from a second study [24] Q&A Session Summary Question: What should be watched next regarding Pfizer litigation? - Management indicated that the scheduling process for the Pfizer case is underway, and more information about the timeline, including a potential trial date, will be available soon [29] Question: Thoughts on Argenx entering the Graves' market? - Management acknowledged the competitive landscape but expressed confidence in their data and the potential for their treatment to be competitive [30][31] Question: Expectations for the upcoming investor day? - Management stated that the investor day will provide a comprehensive overview of the company's transformation and future opportunities [34] Question: Impact of high-dose batoclimab on remission rates in Graves' disease? - Management noted that deeper IgG reductions are expected to drive better outcomes, but they will be cautious in discussing specifics due to competition [36] Question: Update on the competitive landscape in Graves' disease? - Management highlighted the increasing competition but expressed confidence in their FcRn mechanism and the potential for their treatment to be a first-line option [44][45] Question: Plans for exploring other myositis subtypes with BREPO? - Management confirmed that they are considering various indications for BREPO and are excited about the potential opportunities [62]

Financial Data and Key Metrics Changes - The company reported a loss from continuing operations net of tax of $166 million for the quarter [25] - Cash and cash equivalents stood at $4.4 billion with no debt on the balance sheet, indicating a strong capital position [25][6] - The company has authorized $500 million for potential capital return [6] Business Line Data and Key Metrics Changes - The company highlighted significant progress in its late-stage pipeline, with 11 potentially registrational trials and indications with blockbuster potential [6] - Brepocitinib's data in dermatomyositis (DM) hit all 10 ranked endpoints, with an NDA filing planned for the first half of next year [4][15] - Batoclimab showed disease-modifying potential in Graves' disease, with a significant portion of patients achieving remission [20][21] Market Data and Key Metrics Changes - The company noted a large patient population for Graves' disease, with 880,000 diagnosed patients in the U.S., of which 330,000 are uncontrolled or intolerant to current therapies [19] - The unmet need in DM is underscored by the fact that 75% of patients are on either steroids or immunosuppressive therapies, struggling to achieve well-controlled status [10][11] Company Strategy and Development Direction - The company is focused on expanding its pipeline and achieving profitability through its current projects [6][25] - There is an emphasis on the potential for blockbuster launches across multiple indications, particularly in DM and Graves' disease [7][8] - The management expressed excitement about the upcoming investor day on December 11, 2025, to discuss future strategies and developments [26] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a transformative moment for the business, with significant data releases and upcoming NDA submissions [4][8] - The competitive landscape in Graves' disease is evolving, with other companies entering the space, but management remains confident in their position and strategy [29][42] - The company is optimistic about the upcoming data readouts and their implications for future growth [48][51] Other Important Information - The company is involved in ongoing litigation related to LNP technology, with trials scheduled for March 2026 [25][24] - The TED study is on track to conclude this year, with data expected to be reported in conjunction with other studies [23] Q&A Session Summary Question: What should be watched next regarding Pfizer litigation? - Management indicated that the scheduling process for the Pfizer case is underway, and more information about the timeline, including a potential trial date, will be available soon [28] Question: Thoughts on Argenx entering Graves' disease? - Management acknowledged the competitive landscape but expressed confidence in their data and the potential for their treatment to stand out [29] Question: What to expect from the investor day? - Management stated that the investor day will provide a comprehensive overview of the company's transformation and future opportunities, with potential new data to be shared [32] Question: Impact of high-dose batoclimab on remission rates in Graves' disease? - Management noted that deeper IgG reductions are expected to drive better outcomes, and they are analyzing the data to understand the impact [34][35] Question: Update on the competitive landscape in Graves' disease? - Management highlighted the excitement around increased competition but emphasized their strong data and understanding of the FcRn mechanism as a competitive advantage [42][43] Question: Plans for exploring BREPO in other myositis subtypes? - Management confirmed that they are considering various indications for BREPO and are excited about its potential across multiple areas [56][58]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 was $92 million, representing a 37% year-over-year increase [22] - Adjusted EBITDA was negative $5 million, an improvement of $4 million compared to Q3 2024 [23] - Charging network gross margin increased to 35%, up one percentage point from the previous year [22] Business Line Data and Key Metrics Changes - Charging network revenues reached $56 million, a 33% increase year-over-year [22] - eXtend revenues were $32 million, delivering growth of 46% [22] - Insular revenues were approximately $5 million, up 27% [22] Market Data and Key Metrics Changes - The total energy dispensed on EVgo's network grew to 350 gigawatt-hours over the trailing 12 months, a 13-fold increase since 2021 [20] - The number of stalls in operation increased to 4,590, a 2.7 times increase compared to the end of 2021 [20] Company Strategy and Development Direction - EVgo aims to achieve adjusted EBITDA break-even in Q4 2025, marking a significant milestone for the company [28] - The company is focused on expanding its charging network, with plans to deploy up to 5,000 stalls annually by 2029 without needing additional equity capital [19] - EVgo is enhancing its next-generation charging architecture to improve customer experience and reduce capital expenditures per stall by over 25% by 2029 [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth of EV sales, noting that the number of battery electric vehicle models has increased significantly [30] - The company anticipates continued strong demand for its charging services, driven by the increasing number of EVs on the road and the expansion of affordable vehicles [6][7] - Management acknowledged potential challenges in EV demand forecasts but remains confident in the long-term growth trajectory [30] Other Important Information - EVgo has received $41 million from the DOE loan to accelerate the nationwide build-out of EV charging infrastructure [4] - The company has made significant progress in reducing net capital expenditures per stall, now expected to be $75,000 for 2025 vintage [16] Q&A Session Summary Question: EV demand outlook and its impact on development - Management noted that EV sales forecasts can fluctuate but expects higher sales than current forecasts due to improved vehicle affordability and performance [30] Question: Tesla charging on EVgo network - Early data shows increased usage of Tesla vehicles at EVgo stations with the installation of NACS cables, but quantification is still in progress [32] Question: Guidance for stall deployment in 2026 - Management indicated that the guidance for public and dedicated stalls in 2026 remains at 1,350-1,500, with a focus on generating strong returns on capital [35] Question: Impact of contract closeout on revenue - The contract closeout will not affect the prior range of expectations for public and dedicated build targets [56] Question: Charging network gross margin expansion - Management expects continued expansion of charging network gross margin driven by increased usage per stall and fixed cost leverage [59]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $2.3 billion, representing a 10.5% increase on a reported basis and an 8% increase on a like-for-like basis, reflecting strong underlying growth across segments [13] - Net income decreased due to a $10 million loss in discontinued operations and an $8 million non-cash fair value charge, partially offset by $10 million in insurance proceeds and higher earnings in equity method investments [13] - Adjusted EBITDA decreased by $1.3 million, primarily due to declines in fresh fruit, while adjusted net income decreased by $3 million [13][14] Business Line Data and Key Metrics Changes - Fresh fruit revenue increased by 11%, driven by higher volumes and pricing of bananas, pineapples, and plantains, but faced higher sourcing costs impacting adjusted EBITDA [14] - Diversified EMA segment reported an 11% revenue increase, with adjusted EBITDA rising by 34%, driven by strong performances in Scandinavia, Spain, and the Netherlands [15] - Diversified Americas segment saw an 8% revenue increase, with adjusted EBITDA up by 46%, attributed to strong performance in the southern hemisphere export business and North American market [15] Market Data and Key Metrics Changes - Demand for bananas remained robust in North America and Europe, contributing to tight supply and cost pressures [10] - The diversified EMA segment continued to show positive momentum, particularly in Spain and the Netherlands, benefiting from increased investments in distribution and logistics [10][11] Company Strategy and Development Direction - The company completed the sale of its non-core fresh vegetable division, enhancing capital allocation flexibility and allowing for a $100 million share repurchase program [5][6] - The launch of the new Dole Collada Royale Pineapple represents a strategic investment in product innovation, aimed at enhancing the tropical portfolio and community support [7] - The company is focused on integrating operations and streamlining its business model to enhance efficiency and customer attractiveness [11][52] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year adjusted EBITDA at the upper end of the targeted range of $380-$390 million, despite macroeconomic volatility and industry-specific challenges [19] - The company is optimistic about the long-term growth potential within the sector, emphasizing the importance of a diversified business model [19][62] Other Important Information - Cash capital expenditure for the quarter was $20.9 million, with a reduction in full-year routine capital expenditure expectations to approximately $85 million [16][17] - The company declared an $8.50 dividend for Q3, to be paid on January 6th [18] Q&A Session Summary Question: Outlook for Q4 and 2026 - Management acknowledged the challenges in forecasting due to macroeconomic volatility and highlighted specific headwinds in sourcing costs, particularly for bananas, impacting Q4 guidance [22][24] Question: Tariffs and Exclusions - Management stated there were no new updates on tariff exclusions for tropical produce but expressed confidence in the long-term positive changes for the industry [26][27] Question: Capital Allocation and Buyback Program - The buyback program was introduced to provide flexibility in capital allocation, with management emphasizing the importance of balancing dividends, buybacks, and investment opportunities [34][36] Question: Annual Contracting Negotiations - Management indicated that negotiations with customers are ongoing, with awareness of supply conditions impacting discussions [46][48] Question: Strength in Diversified Fresh Produce - Management highlighted strong consumer demand and the company's robust position in the diversified segment across various European markets [50][52]

Financial Data and Key Metrics Changes - Total net revenue for Q3 2025 was $106.8 million, within the guidance range of $106.5-$108.5 million, reflecting a decline of 7.4% year-over-year [24] - Adjusted EBITDA for Q3 2025 was $22 million, also within the guidance range of $22-$23 million, representing a decline of 13.6% year-over-year [24] - Adjusted EBITDA margins, excluding political revenue, improved slightly from 20% in Q3 2024 to 20.5% in Q3 2025 [24] Business Line Data and Key Metrics Changes - Digital revenue grew by 2% year-over-year in the first nine months of 2025, accounting for 55% of total net revenue [6] - Townsquare Ignite, the digital advertising segment, experienced a slight revenue decline of 1.6% year-over-year in Q3 2025 [24] - Townsquare Interactive, the subscription-based digital marketing solution, saw a revenue decrease of 2.3% year-over-year in Q3 2025, but segment profit increased by 21% year-over-year [25][17] Market Data and Key Metrics Changes - Broadcast advertising net revenue, excluding political, declined by 8.1% year-over-year in Q3 2025 [26] - The company gained local and national broadcast market share despite overall declines in the industry [20] - The digital advertising market is facing significant headwinds due to declines in search engine traffic, impacting remnant inventory revenue [14] Company Strategy and Development Direction - The company is focused on being a digital-first local media company, with plans to invest heavily in digital solutions and markets outside the top 50 in the U.S. [7] - The digital advertising segment is expected to continue as the primary growth driver, with a strong emphasis on programmatic advertising [10] - The company aims to maintain a high-yielding dividend while reducing debt and investing in digital growth [30] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging macroeconomic environment but expressed confidence in the digital-first strategy and long-term growth potential [33] - The company expects continued strength in programmatic and direct sales, despite ongoing headwinds from declining search referral traffic [21] - Full-year revenue guidance was revised down due to unexpected declines in search engine traffic and political revenue [31] Other Important Information - The company generated $18 million in cash flow from operations in the first nine months of 2025, with a net loss of $5.5 million in Q3 2025 [26][28] - The company has reduced outstanding debt by $17 million since February 2025 [28] - The board approved a quarterly dividend of $0.20 per share, equating to an annualized payment of approximately $13 million [30] Q&A Session Summary Question: Stabilization of Core Advertising - Management noted that core advertising is experiencing a secular decline, but slight improvements are expected in Q4 2025 and into 2026, with projections of low to mid-single-digit declines [39][40] Question: Profit Margins and Cost Management - Management confirmed that there are opportunities for further cost reductions and efficiency improvements, particularly through AI solutions [41] Question: Government-Related Advertising Impact - Management indicated that there has been no positive impact from government-related advertising due to the shutdown, with some clients reporting canceled orders [42][43] Question: Townsquare Interactive's West Coast Expansion - Management expressed satisfaction with the progress of the Phoenix office and the performance of Townsquare Interactive, highlighting significant profit growth despite stagnant revenue [44][46] Question: Future Profitability Expectations for Interactive - Management expects Townsquare Interactive to maintain low to mid-30% profit margins over the next couple of years, with potential for expansion thereafter [49]

Financial Data and Key Metrics Changes - Company reported total revenue of $1.115 billion for Q3 2025, reflecting a year-on-year growth of 7.5% in USD terms [24] - EBITDA for the quarter was $524 million, representing a growth of 19.7%, with an EBITDA margin of 47%, up 400 basis points year-on-year [25] - Last 12-month EPS stands at $8.89, up 60.2% year-on-year, although reported EPS for Q3 alone was a loss of $1.84 per share due to non-cash charges [8][9] Business Line Data and Key Metrics Changes - Direct digital revenues grew 63% year-on-year to reach $198 million, now accounting for 17.8% of total revenues, up from 11% a year ago [25] - Telecom and infrastructure segment revenues grew 3.5% on a like-for-like basis, reflecting the impact of differentiated networks and services [8] - Multiplay customers generated 3.8 times the ARPU of voice-only subscribers, with 55.4% of total customer revenues coming from this segment, which grew revenue-wise by 23% year-on-year [12][13] Market Data and Key Metrics Changes - Strong double-digit revenue growth was delivered across all markets except Bangladesh, which saw a return to year-on-year growth for the first time in 14 months [14] - In Pakistan, the financial services business gross transaction value rose 40% year-on-year, representing 13% of the country's GDP [15] - The digital-only user base has more than doubled to 50 million, representing nearly 35% of total digital users [17] Company Strategy and Development Direction - The company is focused on a digital operator model, combining connectivity, digital platforms, and financial inclusion to unlock sustainable growth [4] - The asset-light strategy continues with the sale of Kyrgyzstan operations and a global framework agreement with Starlink for satellite connectivity [6] - The company is exploring opportunities for further investment in Ukraine, aligning with its "Invest in Ukraine Now" initiative [35] Management's Comments on Operating Environment and Future Outlook - Management raised the fiscal year 2025 EBITDA outlook to 16%-18% growth in local currency terms, up from 14%-16% [4] - The company remains confident in its growth trajectory despite macro and geopolitical challenges, with a focus on sustaining long-term value creation [29][30] - Management emphasized the importance of operational cost management and disciplined pricing actions in supporting margin improvements [58] Other Important Information - The company completed the operational separation of JazzCash, enhancing growth potential in digital financial services [15] - A $100 million share and/or bond repurchase program was approved by the board, reflecting confidence in growth prospects [7] - The company ended the quarter with a cash balance of $1.67 billion, including $653 million at headquarters [26] Q&A Session Summary Question: Motivation for Kyivstar's SPAC transaction - Management chose a SPAC structure for its deal certainty and speed, believing it was the right move to list Kyivstar successfully [34] Question: Plans for cash at headquarters - The cash at headquarters is $653 million, with limitations on upstreaming due to martial law in Ukraine, focusing on investments in the country [38] Question: Future of tower assets in Ukraine - The company aims to pursue divestment of tower assets in Ukraine, similar to its strategy in Pakistan, to enhance cash generation [45] Question: Financial services in Pakistan - The financial services business targets unbanked individuals, with microloans providing essential support to small businesses [49] Question: Growth of JazzCash and MMBL - The company plans to leverage capabilities from JazzCash and MMBL to expand fintech services in other markets, focusing on smartphone penetration [72] Question: Ride-hailing market expansion - The company has ambitions to grow its ride-hailing business in other markets, with a city-by-city operational strategy [80] Question: Trade-off between scale and profitability - Management noted that digital services have not diluted EBITDA margins as expected, attributing this to operational cost discipline [58] Question: Run rate for financial services EBITDA - The financial services business has shown steady growth, with expectations for continued performance in the coming quarters [95]